| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haematological malignancies v0.44 | MSH2 | Bryony Thompson Marked gene: MSH2 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Haematological malignancies v0.44 | MSH2 | Bryony Thompson Gene: msh2 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Haematological malignancies v0.44 | MSH2 | Bryony Thompson reviewed gene: MSH2: Rating: GREEN; Mode of pathogenicity: None; Publications: 25883011, 40734770; Phenotypes: Mismatch repair cancer syndrome 2, MONDO:0030840; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Haematological malignancies v0.0 | MSH2 |
Bryony Thompson gene: MSH2 was added gene: MSH2 was added to Haematological malignancies cancer susceptibility. Sources: Curated sources,Expert Review Green Mode of inheritance for gene: MSH2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: MSH2 were set to 27881370; 28297620 Phenotypes for gene: MSH2 were set to Class: Familial cancer syndrome; Constitutional mismatch repair deficiency; Lymphoma, ALL, MDS, AML; Brain tumors, gastrointestinal cancers, GI (colon), ovarian, uterine, CNS, other |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||